| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.084 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |